Abstract
Background and Objectives Stroke is the leading cause of long-term disability, making the search for successful rehabilitation treatment one of the most important public health issues. A better understanding of the neural mechanisms underlying impairment and recovery and the development of associated markers is critical for tailoring treatments to each individual patient with the ultimate goal of maximizing therapeutic outcomes.
Methods Here, we used a novel and powerful method consisting of combined transcranial magnetic stimulation (TMS) and multichannel electroencephalography (EEG) to analyze TMS-induced brain oscillations in a large cohort of 60 stroke patients from the acute to the early-chronic phase after a stroke.
Results A data-driven parallel factor analysis (PARAFAC) approach to tensor decomposition allowed to detect brain oscillatory modes specifically centered on the θ, α and β frequency bands, which evolved longitudinally across stroke stages. Notably, the observed modulations of the α-mode, which is known to be linked with GABAergic system activity, were associated to the extent of motor recovery.
Discussion Overall, these longitudinal changes provide novel insights into the functional reorganization of brain networks after a stroke and its underlying mechanisms. Notably, we propose that the observed α-mode decrease corresponds to a beneficial disinhibition phase between the subacute and early-chronic stage that fosters structural and functional plasticity and facilitates recovery. Monitoring this phenomenon at the individual patient level will provide critical information for phenotyping patients, developing electrophysiological biomarkers and refining therapies based on personalized excitatory/inhibitory neuromodulation using noninvasive or invasive brain stimulation techniques.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was supported by grants from the Personalized Health and Related Technologies (PHRT-#2017-205) of the ETH Domain (CH), the Defitech Foundation (Strike-the-Stroke project, Morges, CH), the SNSF (NIBS-iCog, 320030L_197899 / 1) and the Wyss Center for Bio- and Neuroengineering (WP030; Geneva, CH).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The study was conducted in accordance with the Declaration of Helsinki and was approved by Cantonal Ethics Committee Vaud, Switzerland (project number: 2018-01355). Written informed consent was obtained from all participants.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
One major and one minor change have been made in this revision. Firstly, we have established and discussed links between the present findings and those obtained from the same cohort, when focusing on brain reactivity as assessed with TMS-evoked potentials (see new Fig. 6). These results are detailed in another preprint on MedRXiv (Harquel et al., 2023). Secondly, we have added details to the Results section, including the incorporation of control tests and clarification of terminology.
Data Availability
The data related to this article are available upon reasonable request from the corresponding author.
